Development of an assay to screen for inhibitors of tau phosphorylation by cdk5

被引:14
作者
Ahn, JS
Musacchio, A
Mapelli, M
Ni, J
Scinto, L
Stein, R
Kosik, KS
Yeh, LA
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis,Lab Drug Discovery Neurodegenerat, Boston, MA USA
[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Neurol,Lab Higher Cort Funct, Boston, MA USA
[3] European Inst Oncol, Dept Expt Oncol, Milan, Italy
关键词
HTS; cdk5; tau phosphorylation; Alzheimer's disease;
D O I
10.1177/1087057103260594
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A high-throughput assay for tau phosphorylation by cdk5/p25 is described. Full-length recombinant tau was used as a substrate in the presence of saturating adenosine triphosphate (ATP). Using PHF-1, an antibody directed specifically against 2 tau phosphorylation epitopes (serine 396 and serine 404), an enzyme-linked immunosorbent assay (ELISA)-based colorimetric assay was formatted in 384-well plates. The assay was validated by measuring kinetic parameters for cdk5/p25 catalysis and known inhibitors. Rate constants for the site-specific phosphorylations at the PHF-1 epitopes were determined and suggested preferential phosphorylation at these sites. The performance of this assay in a high-throughput format was demonstrated and used to identify inhibitors of tau phosphorylation at specific epitopes phosphorylated by cdk5/p25.
引用
收藏
页码:122 / 131
页数:10
相关论文
共 40 条
[21]   TAU DOMAINS, PHOSPHORYLATION, AND INTERACTIONS WITH MICROTUBULES [J].
MANDELKOW, EM ;
BIERNAT, J ;
DREWES, G ;
GUSTKE, N ;
TRINCZEK, B ;
MANDELKOW, E .
NEUROBIOLOGY OF AGING, 1995, 16 (03) :355-362
[22]   GLYCOGEN-SYNTHASE KINASE-3 AND THE ALZHEIMER-LIKE STATE OF MICROTUBULE-ASSOCIATED PROTEIN TAU [J].
MANDELKOW, EM ;
DREWES, G ;
BIERNAT, J ;
GUSTKE, N ;
VANLINT, J ;
VANDENHEEDE, JR ;
MANDELKOW, E .
FEBS LETTERS, 1992, 314 (03) :315-321
[23]   BIOPSY-DERIVED ADULT HUMAN BRAIN TAU IS PHOSPHORYLATED AT MANY OF THE SAME SITES AS ALZHEIMERS-DISEASE PAIRED HELICAL FILAMENT-TAU [J].
MATSUO, ES ;
SHIN, RW ;
BILLINGSLEY, ML ;
VANDEVOORDE, A ;
OCONNOR, M ;
TROJANOWSKI, JQ ;
LEE, VMY .
NEURON, 1994, 13 (04) :989-1002
[24]   Properties and potential applications of chemical inhibitors of cyclin-dependent kinases [J].
Meijer, L ;
Leclerc, S ;
Leost, M .
PHARMACOLOGY & THERAPEUTICS, 1999, 82 (2-3) :279-284
[25]   Inhibition of cyclin-dependent kinases, GSK-3β and CK1 by hymenialdisine, a marine sponge constituent [J].
Meijer, L ;
Thunnissen, AMWH ;
White, AW ;
Garnier, M ;
Nikolic, M ;
Tsai, LH ;
Walter, J ;
Cleverley, KE ;
Salinas, PC ;
Wu, YZ ;
Biernat, J ;
Mandelkow, EM ;
Kim, SH ;
Pettit, GR .
CHEMISTRY & BIOLOGY, 2000, 7 (01) :51-63
[26]   Aloisines, a new family of CDK/GSK-3 inhibitors. SAR study, crystal structure in complex with CDK2, enzyme selectivity, and cellular effects [J].
Mettey, Y ;
Gompel, M ;
Thomas, V ;
Garnier, M ;
Leost, M ;
Ceballos-Picot, I ;
Noble, M ;
Endicott, J ;
Vierfond, JM ;
Meijer, L .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (02) :222-236
[27]   PROLINE-DIRECTED AND NON-PROLINE-DIRECTED PHOSPHORYLATION OF PHF-TAU [J].
MORISHIMAKAWASHIMA, M ;
HASEGAWA, M ;
TAKIO, K ;
SUZUKI, M ;
YOSHIDA, H ;
TITANI, K ;
IHARA, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (02) :823-829
[28]   MONOCLONAL-ANTIBODY PHF-1 RECOGNIZES TAU-PROTEIN PHOSPHORYLATED AT SERINE RESIDUE-396 AND RESIDUE-404 [J].
OTVOS, L ;
FEINER, L ;
LANG, E ;
SZENDREI, GI ;
GOEDERT, M ;
LEE, VMY .
JOURNAL OF NEUROSCIENCE RESEARCH, 1994, 39 (06) :669-673
[29]   Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration [J].
Patrick, GN ;
Zukerberg, L ;
Nikolic, M ;
de la Monte, S ;
Dikkes, P ;
Tsai, LH .
NATURE, 1999, 402 (6762) :615-622
[30]  
PAUDEL HK, 1993, J BIOL CHEM, V268, P23512